Accessibility Menu
 
Amplifon S.p.A. logo

Amplifon S.p.A.

(OTC) AMFPF

Current Price$10.09
Market Cap$2.22B
Since IPO (2003)-62%
5 Year-73%
1 Year-53%
1 Month-36%

Amplifon S.p.A. Financials at a Glance

Market Cap

$2.22B

Revenue (TTM)

$2.40B

Net Income (TTM)

$91.34M

EPS (TTM)

$0.45

P/E Ratio

22.32

Dividend

$0.33

Beta (Volatility)

-0.09 (Low)

Price

$10.09

Volume

1,600

Open

$10.09

Previous Close

$10.09

Daily Range

$10.09 - $10.09

52-Week Range

$9.46 - $23.85

AMFPF News

No articles available.

AMFPF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Amplifon S.p.A.

Industry

Healthcare Providers and Services

Employees

15,078

CEO

Enrico Vita

Headquarters

Milan, MI 20141, IT

AMFPF Financials

Key Financial Metrics (TTM)

Gross Margin

15%

Operating Margin

9%

Net Income Margin

4%

Return on Equity

9%

Return on Capital

7%

Return on Assets

3%

Earnings Yield

4.48%

Dividend Yield

0.03%

Payout Ratio

71.50%

Stock Overview

Market Cap

$2.22B

Shares Outstanding

219.94M

Volume

1.60K

Short Interest

0.00%

Avg. Volume

330.936

Financials (TTM)

Gross Profit

$198.94M

Operating Income

$198.94M

EBITDA

$513.90M

Operating Cash Flow

$274.74M

Capital Expenditure

$274.74M

Free Cash Flow

$0.00

Cash & ST Invst.

$0.00

Total Debt

$1.53B

Amplifon S.p.A. Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$651.64M

-1.2%

Gross Profit

$48.66M

-94.9%

Gross Margin

7.47%

N/A

Market Cap

$2.22B

N/A

Market Cap/Employee

$191.21K

N/A

Employees

11,603

N/A

Net Income

$16.90M

-59.0%

EBITDA

$126.54M

-17.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$1.53B

-6.9%

Accounts Receivable

$334.92M

+9.1%

Inventory

$82.42M

-11.5%

Long Term Debt

$1.47B

+10.0%

Short Term Debt

$57.49M

-84.9%

Return on Assets

2.56%

N/A

Return on Invested Capital

7.38%

N/A

Free Cash Flow

$0.00

-100.0%

Operating Cash Flow

$54.93M

-72.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CZMWFCarl Zeiss Meditec AG
$27.91+0.00%
CZMWYCarl Zeiss Meditec AG
$28.40-0.35%
AMBBYAmbu A/S
$10.32-3.17%
NHNKYNihon Kohden Corporation
$9.00-1.53%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About AMFPF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.